Seminars in Liver Disease

Articles Available on Medscape

• Nonalcoholic Steatohepatitis and Noncirrhotic Hepatocellular Carcinoma: Fertile Soil
  Who is most at risk for contracting hepatocellular carcinoma? Is it patients with NASH? This new study takes a look at the risk for disease.

  April 25, 2012

• The Impact of Bariatric Surgery on Nonalcoholic Steatohepatitis
  Does bariatric surgery potentially help patients living with NASH and NAFLD, and how great is the impact on their quality of life?

  April 11, 2012

• The Era of Direct-acting Antivirals Has Begun
  How are newer direct-acting antivirals, particularly in combination, changing the treatment landscape in hepatitis C?

  February 15, 2012

• What Is Killing People With Hepatitis C Virus Infection?
  What is it about hepatitis C that makes it such a potentially deadly disease? This new study takes a close look at the disease.

  February 01, 2012

• Natural History and Management of HFE-Hemochromatosis
  What is the connection between hemochromatosis and liver disease? This study examines the diseases in relation to each other.

  January 18, 2012

• Wilson Disease: Pathogenesis and Clinical Considerations in Diagnosis and Treatment
  Are there new advances in the diagnosis of Wilson's disease, and how should the disease be treated once discovered?

  January 12, 2012

• Genetics of Alcoholic and Nonalcoholic Fatty Liver Disease
  How do both alcoholic and nonalcoholic fatty liver disease develop, and are there some similarities in the pathophysiology of each disease?

  August 01, 2011

• Understanding the Host Genetics of Chronic Hepatitis B and C
  How do genes contribute to treatment outcomes in both hepatitis B and hepatitis C infections?

  July 05, 2011

• Assessment of Fibrosis and Cirrhosis in Liver Biopsies
  What can needle biopsies of the liver tell us about the progression of both fibrosis and cirrhosis?

  June 24, 2011

• Intrahepatic Cholangiocarcinoma: New Insights in Pathology
  How does hepatitis C infection potentially put a patient at risk for intrahepatic cholangiocarcinoma?

  June 17, 2011

• The Role of Inflammation in Cholestasis: Clinical and Basic Aspects
  How does cholestasis develop, and what role does inflammation play? This study explores the issue.

  August 13, 2010

• Genetic Determinants of Drug-induced Cholestasis and Intrahepatic Cholestasis of Pregnancy
  This article looks at the pathophysiology of various types of cholestasis, with a focus on the genetic determinants.

  July 14, 2010

• Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury
  This article reviews the promises and challenges in developing and validating biomarkers that could help HCPs distinguish DILI from other causes of liver injury and identify the causative drug.

  December 02, 2009

• The Natural History of Drug-Induced Liver Injury
  This article focuses on the natural history of acute hepatocellular injury with jaundice in patients with drug-induced liver injury.

  November 04, 2009

• Autoimmune Hepatitis and Liver Transplantation: Indications, Results, and Management of Recurrent Disease
  This article reviews the diagnostic criteria for AIH, the indications for and results of liver transplantation, as well as the management of recurrent AIH disease.

  August 31, 2009

• Treatment of Autoimmune Hepatitis
  AIH is a treatable disease in the majority of cases, but complex issues such as timely diagnosis, avoidance of treatment side effects, nonresponse and adherence to standard induction therapy remain.

  August 31, 2009

• Role of Alcohol in Liver Carcinogenesis
  Chronic alcohol consumption has long been associated with progressive liver disease. It may also increase the risk of developing hepatocellular carcinoma, one of the most common malignant tumors.

  July 24, 2009

• Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease
  NAFLD has become commonplace in clinical practice due to the rise of obesity and metabolic syndrome. Without one ideal therapy, what are some of the current and potential future therapies for NAFLD?

  December 31, 2008

• The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
  Nonalcoholic fatty liver disease is an increasingly recognized cause of liver disease globally. This overview provides an epidemiological background on the prevalence and risk factors for NAFLD.

  December 24, 2008

• Benign and Malignant Vascular Tumors of the Liver in Adults
  Vascular tumors of the liver in adult patients include cavernous hemangioma, a common benign tumor; epithelioid hemangioendothelioma, a rare, usually low-grade malignant tumor; and angiosarcoma, a rare and very aggressive tumor.

  December 19, 2008